PPARG and diabetes mellitus: In addition to blocking the renin-angiotensin system, telmisartan acts as a selective modulator of PPARγ, a central regulator of insulin and glucose metabolism and a well-known target of insulin-sensitizing drugs used to treat type 2 diabetes mellitus [9].